Guidance: Sickle cell and thalassaemia screening: care pathway
This document describes the sickle cell and thalassamia (SCT) screening pathways.
This document describes the sickle cell and thalassamia (SCT) screening pathways.
Screening data for the NHS sickle cell and thalassaemia (SCT) screening programme for the year 1 April 2018 to 31 March 2019.
Information for people who have had their first COVID-19 vaccination.
Information for eligible adults on COVID-19 vaccination.
Information on the enhanced surveillance of coronavirus (COVID-19) cases in vaccinated individuals.
Description and contact details of PHE paediatric surveillance programmes for COVID-19.
Consensus statement from Public Health England, the Health and Safety Executive and the Faculty of Occupational Medicine.
Details of the services offered by the PHE Office for Data Release (ODR) and guidance on how to access PHE held data.
Data on the real-world efficacy of the COVID-19 vaccines.
Guidance on detecting gonorrhoea, including dual nucleic acid amplification tests (NAATs) for chlamydia and gonorrhoea.